leisure time -WSS

leisure time

author：leisure time 2025-09-30 15:16:53 - browse：4

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

WSS

Illumina names Agilent executive as new CEO

Judge rejects Trump's counterclaim against E. Jean Carroll

Astronauts get first look at the spacecraft that will fly them around the moon

AstraZeneca chief proposes a novel edit to the drug pricing bill

Weighted lottery helped low

Snackable artificial intelligence, expert AI, and the pharma industry

focus

leisure time

Wikipedia

Cancer drug shortages should be causing more outrage

Medicaid rebukes states for mistakenly disenrolling children

Cancer drug shortages should be causing more outrage

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Jerome Adams on the need for new antivirals for Covid

Snackable artificial intelligence, expert AI, and the pharma industry

How one medical school became remarkably diverse

Ohioans vote in high

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Discs beat pads, tampons for heavy menstrual flow, new study shows

knowledge

House transparency, PBM reform bill gains bipartisan support

FTX founder Sam Bankman

More regulation could be coming for drug ads

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

'Make People Better': The CRISPR babies story you probably don't know

Former Georgia lieutenant governor says he received grand jury subpoena

Wikipedia

Wikipedia

focus

knowledge